Shon M.p.h. on venous thromboembolism
From Ep. 19: Bringing Paradigm Changing Devices to Market ft. Shon Chakrabarti · · SSI Strategy
“At Inari Medical, we are shifting treatment for venous thromboembolism from systemic medical therapy like anticoagulants to a simple device-based removal approach, which could have significant short and long-term benefits for patients.”
On , Shon M.p.h., Chief Medical Officer of LimFlow at INARI MEDICAL INC, spoke about venous thromboembolism during Ep. 19: Bringing Paradigm Changing Devices to Market ft. Shon Chakrabarti on SSI Strategy.
About Shon M.p.h.
Shon Chakrabarti, an interventional cardiologist by training, serves as Vice President of Medical Affairs and General Manager of Chronic Venous Therapies at Inari Medical. In a September 2023 podcast appearance, he discussed his transition from clinical practice to medical device leadership, describing the shift as requiring a willingness to "get comfortable with discomfort." He stated that his role involves shifting treatment for venous thromboembolism from systemic medical therapy to a device-based removal approach, which he said could have significant benefits for patients. Chakrabarti also reflected on his experience at Abiomed, where he said the company developed a non-permanent temporary implantable pump to bridge patients in cardiogenic shock to heart recovery. He emphasized that medical device technology should address an unmet need and aim to change treatment paradigms, not just add a tool to a toolbox. He advised physicians considering a path to industry leadership to reflect on their goals, stay open-minded, and be prepared for a new training journey that requires full commitment.